Institutional investors purchased a net $261.9 thousand shares of TARO during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 14.86% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AJO LP Bought 166.8 Thousand shares of Taro Pharmaceutical Indus...